JP2011520847A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011520847A5 JP2011520847A5 JP2011508945A JP2011508945A JP2011520847A5 JP 2011520847 A5 JP2011520847 A5 JP 2011520847A5 JP 2011508945 A JP2011508945 A JP 2011508945A JP 2011508945 A JP2011508945 A JP 2011508945A JP 2011520847 A5 JP2011520847 A5 JP 2011520847A5
- Authority
- JP
- Japan
- Prior art keywords
- ethoxy
- xaa
- acetyl
- amino
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 0 *C(CCC(NCCOCC*CCOCCOCC(NCCCC[C@](C(P)=O)N*)O)O)[N+]([O-])=O Chemical compound *C(CCC(NCCOCC*CCOCCOCC(NCCCC[C@](C(P)=O)N*)O)O)[N+]([O-])=O 0.000 description 8
- XJXNZODHKPMSDQ-PLNGDYQASA-N C/C(/C(C)=O)=C/C(N)=C Chemical compound C/C(/C(C)=O)=C/C(N)=C XJXNZODHKPMSDQ-PLNGDYQASA-N 0.000 description 1
- CVMXXJSHVQQZRG-UHFFFAOYSA-N CC1CCC(CNC(CCCCCCCCCCCCCCCCCCC(O)[U])[U])CC1 Chemical compound CC1CCC(CNC(CCCCCCCCCCCCCCCCCCC(O)[U])[U])CC1 CVMXXJSHVQQZRG-UHFFFAOYSA-N 0.000 description 1
- JRMQQXSMFOBGII-UHFFFAOYSA-N O=CCCCCCCCCCCCCCCCCCNCC1CCCCC1 Chemical compound O=CCCCCCCCCCCCCCCCCCNCC1CCCCC1 JRMQQXSMFOBGII-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08156360 | 2008-05-16 | ||
| EP08156360.3 | 2008-05-16 | ||
| EP09154461 | 2009-03-05 | ||
| EP09154461.9 | 2009-03-05 | ||
| PCT/EP2009/055989 WO2009138511A1 (en) | 2008-05-16 | 2009-05-18 | Long-acting y2 and/or y4 receptor agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011520847A JP2011520847A (ja) | 2011-07-21 |
| JP2011520847A5 true JP2011520847A5 (https=) | 2012-07-05 |
Family
ID=40934036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011508945A Withdrawn JP2011520847A (ja) | 2008-05-16 | 2009-05-18 | 遅効型ｙ２及び／又はｙ４レセプターアゴニスト |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20110275559A1 (https=) |
| EP (1) | EP2279204A1 (https=) |
| JP (1) | JP2011520847A (https=) |
| KR (1) | KR20110017874A (https=) |
| CN (1) | CN102027007A (https=) |
| AU (1) | AU2009248041B2 (https=) |
| BR (1) | BRPI0912615A2 (https=) |
| CA (1) | CA2723855A1 (https=) |
| IL (1) | IL208836A0 (https=) |
| MX (1) | MX2010011845A (https=) |
| RU (1) | RU2504550C2 (https=) |
| WO (1) | WO2009138511A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9260500B2 (en) | 2009-07-02 | 2016-02-16 | Takeda Pharmaceutical Company Limited | Peptide and use thereof |
| EP2477643A1 (en) * | 2009-09-18 | 2012-07-25 | Novo Nordisk A/S | Long-acting y2 receptor agonists |
| WO2011058165A1 (en) * | 2009-11-13 | 2011-05-19 | Novo Nordisk A/S | Long-acting y2 receptor agonists |
| GB201001333D0 (en) * | 2010-01-27 | 2010-03-17 | Imp Innovations Ltd | Novel compounds and their effects on feeding behaviour |
| EP2600887A4 (en) | 2010-07-09 | 2014-01-22 | Amylin Pharmaceuticals Llc | MICROCRYSTALLINE Y RECEPTOR AGONISTS |
| MX377589B (es) | 2010-12-16 | 2025-03-10 | Novo Nordisk As | Composiciones sólidas que comprenden agonista de glp-1 y sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílico. |
| CN104203266B (zh) | 2012-03-22 | 2017-12-26 | 诺和诺德股份有限公司 | Glp‑1肽组合物及其制备 |
| JP6672140B2 (ja) | 2013-05-02 | 2020-03-25 | ノヴォ ノルディスク アー／エス | Ｇｌｐ−１化合物の経口投薬 |
| EP2842965A1 (en) | 2013-09-03 | 2015-03-04 | Gubra ApS | Neuromedin U analogs comprising serum albumin binding amino acid residue |
| US10583172B2 (en) | 2013-11-15 | 2020-03-10 | Novo Nordisk A/S | HPYY(1-36) having a beta-homoarginine substitution at position 35 |
| WO2015073878A1 (en) * | 2013-11-15 | 2015-05-21 | Ur Diet, Llc | Real-time satiety biofeedback |
| MX369818B (es) | 2013-11-15 | 2019-11-22 | Novo Nordisk As | Compuestos selectivos de peptido yy (pyy) y usos de los mismos. |
| DK3068421T3 (da) * | 2013-11-15 | 2019-06-24 | Novo Nordisk As | Selektive pyy-forbindelser og anvendelser deraf |
| US20240100450A9 (en) * | 2014-01-17 | 2024-03-28 | Repligen Corporation | Sterilizing chromatography columns |
| US10610807B2 (en) | 2014-01-17 | 2020-04-07 | Repligen Corporation | Sterilizing chromatography columns |
| CN114805527A (zh) * | 2014-05-21 | 2022-07-29 | 哈佛大学的校长及成员们 | Ras抑制肽和其用途 |
| MA43205A (fr) | 2015-06-12 | 2018-09-19 | Novo Nordisk As | Composés pyy sélectifs et leurs utilisations |
| PL3746111T3 (pl) | 2018-02-02 | 2024-01-15 | Novo Nordisk A/S | Stałe kompozycje zawierające agonistę glp-1 i sól kwasu n-(8-(2- hydroksybenzoilo)amino kaprylowego i substancję poślizgową |
| TWI749381B (zh) * | 2018-11-01 | 2021-12-11 | 美商美國禮來大藥廠 | 蛋白質酪胺酸-酪胺酸類似物及其使用方法 |
| GB201908426D0 (en) * | 2019-06-12 | 2019-07-24 | Imp College Innovations Ltd | Appetite suppressing compounds |
| AU2021257477A1 (en) * | 2020-04-17 | 2022-12-08 | I2O Therapeutics, Inc. | Long acting peptide tyrosine tyrosine (PYY) analogs and methods of use |
| CA3215858A1 (en) | 2021-04-27 | 2022-11-03 | Zhenhuan ZHENG | Combination of bitter receptor agonist and gut-signaling compound |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8273713B2 (en) * | 2000-12-14 | 2012-09-25 | Amylin Pharmaceuticals, Llc | Methods of treating obesity using PYY[3-36] |
| KR101241862B1 (ko) * | 2003-09-19 | 2013-03-13 | 노보 노르디스크 에이/에스 | 신규 ｇｌｐ-1 유도체 |
| WO2005077094A2 (en) * | 2004-02-11 | 2005-08-25 | Amylin Pharmaceuticals, Inc. | Pancreatic polypeptide family motifs and polypeptides comprising the same |
| CA2560174A1 (en) * | 2004-03-17 | 2005-09-29 | 7Tm Pharma A/S | Y4 selective receptor agonists for therapeutic interventions |
| MXPA06015049A (es) * | 2004-07-08 | 2007-02-08 | Novo Nordisk As | Marcadores prolongadores de polipeptidos que comprenden una porcion tetrazol. |
| AU2006271792A1 (en) * | 2005-07-18 | 2007-01-25 | Novo Nordisk A/S | Peptides for use in the treatment of obesity |
-
2009
- 2009-05-18 CN CN2009801173043A patent/CN102027007A/zh not_active Withdrawn
- 2009-05-18 AU AU2009248041A patent/AU2009248041B2/en not_active Ceased
- 2009-05-18 KR KR1020107027495A patent/KR20110017874A/ko not_active Withdrawn
- 2009-05-18 MX MX2010011845A patent/MX2010011845A/es not_active Application Discontinuation
- 2009-05-18 EP EP09745843A patent/EP2279204A1/en not_active Withdrawn
- 2009-05-18 RU RU2010149474/04A patent/RU2504550C2/ru not_active IP Right Cessation
- 2009-05-18 CA CA2723855A patent/CA2723855A1/en not_active Withdrawn
- 2009-05-18 WO PCT/EP2009/055989 patent/WO2009138511A1/en not_active Ceased
- 2009-05-18 BR BRPI0912615A patent/BRPI0912615A2/pt not_active Application Discontinuation
- 2009-05-18 US US12/993,015 patent/US20110275559A1/en not_active Abandoned
- 2009-05-18 JP JP2011508945A patent/JP2011520847A/ja not_active Withdrawn
-
2010
- 2010-10-20 IL IL208836A patent/IL208836A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011520847A5 (https=) | ||
| RU2504550C2 (ru) | Длительно действующие агонисты рецепторов y2 и(или) y4 | |
| AU2014241743B2 (en) | Insulin-incretin conjugates | |
| JP2010538049A5 (https=) | ||
| CN114901680B (zh) | 长效glp-1化合物 | |
| TWI783244B (zh) | 升糖素及glp-1共激動劑化合物 | |
| JP2013543497A5 (https=) | ||
| JP6108659B2 (ja) | 代謝疾患および肥満の治療のためのｇｉｐに基づいた混合アゴニスト | |
| US9657079B2 (en) | Truncated GLP-1 derivatives and their therapeutical use | |
| JP2016512213A5 (https=) | ||
| JP2014521684A5 (https=) | ||
| JP2014502252A5 (https=) | ||
| CN108271356A (zh) | 肠降血糖素-胰岛素缀合物 | |
| JP2014521594A5 (https=) | ||
| JP2013545724A5 (https=) | ||
| JP2013510829A (ja) | 長時間作用型ｙ２受容体アゴニスト | |
| JP2008533105A5 (https=) | ||
| JP2014500880A5 (https=) | ||
| JP2012529463A5 (https=) | ||
| CA2812951A1 (en) | Engineered polypeptides having enhanced duration of action | |
| EP2190872A1 (en) | Glucagon-like peptide-1 derivatives and their pharmaceutical use | |
| CN107108716A (zh) | 双相性单链胰岛素类似物 | |
| WO2010111617A4 (en) | Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use | |
| JP2009513654A5 (https=) | ||
| EP1945790A2 (en) | Vasoactive intestinal polypeptide pharmaceuticals |